TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ALLO

Allogene Therapeutics Inc

Healthcare · Biotechnology

1.70$ +0.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ALLO
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – +0.4% -99.4% -60.9% -76.8% -100.0%
– – +235.1% +129.6% +13.2% +28.0% -15.1% -3.9% -9.4%
– – – – – -99.4% -60.9% -76.8% -56,277.3%
– +0.0% -4.8% +33.5% +14.1% +16.4% -5.3% -20.8% -21.9%
– +170,658.3% +40.2% +13.5% +13.6% +7.0% -9.6% -9.0% -12.9%
– +9,642,000.0% +4.8% +27.8% +14.0% +14.1% -2.3% -16.7% -28.8%
– – – – – – – – –
– – +49.7% +82.3% +14.1% +63.7% +0.0% -98.9% +493.9%
– – – – – – – – –
– – – – – – – – –
– – – – – – – – –
– -939,936.4% – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?